Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: Trastuzumab|BIOLOGICAL: MYL- 1401O|DRUG: Paclitaxel|DRUG: Docetaxel
Sponsor: Mylan Inc.
Collaborators: Mylan GmbH